Medtronic plc announced the recent CE Mark and commercial launch for an expanded size matrix of the Resolute Onyx DES, a next-generation drug-eluting stent now available in 4.5 and 5 mm diameter sizes. The CE Mark also approved several new product indications including treatment of left main vessels and small vessels.
